List view / Grid view

Lipids

 

article

Pharmacometabolomics as the key to personalised medicine

12 June 2016 | By ,

Blanketed administration of drugs to all populations assumes that all patients respond similarly. Despite pharmaceutical companies’ efforts to develop drugs with large therapeutic windows, there are often and inevitably subpopulations of individuals who will either not respond to therapy or will respond with adverse effects...